Announcement iZafe Group has confirmed that it has signed a smart partnership deal with Vakt og Alarm. The Vakt og Alarm is one of Norway’s popular providers of alarm and safety services for the welfare and care area. Via this collaboration, Vakt og Alarm will be liable for the installation,...
Announcement After getting near the end of the tunnel with the AAVantgarde closing of the Series B financing round, AGC Biologics is preparing for a new manufacturing agreement with the biotechnology company. This will be a symbol of AGC Biologics’ brand-new advancement in the adeno-based vi...
Announcement Concept Life Sciences, a known contract research organisation (CRO) delivering to the global pharma and Life Sciences industry, has proudly declared that it showcased three new research posters at the 2025 Neuroscience in San Diego, California, during the annual meeting of the Society...
Announcement EVQLV has taken a step ahead in the AI-evolving world to accelerate its business and redefine the healthcare industry's potential values, best aligning with the tech world. The EVQL has introduced Abtique, a first and best the worth online marketplace. At this online marketplace, the ...
Announcement OS Therapies Inc., the champion in listeria-related cancer immunotherapies, is near to offshoot OS Animal Health, Inc. (OSAH) into a standalone public company to be registered on a national stock exchange to accelerate the internal business. OSAH is the company’s wholly owned an...
Announcement According to the Jefferies analysis, drugs that hold strong designations tend to pass the regulatory process more swiftly, thereby increasing their chances of success. Most of the FDA's groundbreaking designations specifically point out the report findings and priority reviews that ha...
Announcement Agios Pharmaceuticals, Inc., a marketing-level biopharmaceutical company attentive on serving the best innovative medicines for patient groups with rare diseases, have unveiled its promising top results from the long-term 52-week global RISE UP Phase 3 trial of an oral pyruvate kinase...
Announcement Alzheon Inc., a clinical-level biopharmaceutical company upgrading in diagnostics and therapeutics for the Alzheimer’s disease (AD) patient group, has confirmed that they will present new safety and efficacy data from the Phase 2 study, lasting for over 3 years. The company will...
Announcement Beacon Biosignals, a well-known neurotechnology company fueling precision medicines and AI-boosted neurodiagnostics for the brain, has expanded its smart partnership with Takeda, which was initiated in 2024, paving the way for success. This expansion accelerates the Beacon Platform to...
Announcement Defence Therapeutics Inc., a known biotechnology company brilliantly working and sharpening its focus on next-generation antibody-drug conjugate (ADC), have climbed one step ahead on the ladder of one more milestone by making an effort to fight cancer that goes beyond the ADC's recent ...
